Your search for apixaban returned 5 results

The summary below gives an overview of some of the important additions and changes MPR has made to its drug database through the end of September. The chart below provides highlights of the 118 key monograph updates made this month (not an inclusive list).

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of October. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of April. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Cardiac drug interactions make up almost 25% of all preventable adverse drug reactions.

This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.